Mood Media is a buy, says Euro Pacific’s Goff

mood media

Shares of Mood Media (TSX:MM) have been falling for nearly two years, but the company now offers an attractive reward for patient investors, says Euro Pacific Canada analyst Rob Goff. In a report to clients this morning, Goff initiated coverage of Mood Media with a “Speculative Buy” rating and a one-year target of $0.75, implying […]

2014 Cantech Letter TSX Venture Tech Exec of the Year: The Finalists

cantechwood

At the 2014 Cantech Investment Conference, Paradigm’s Barry Richards predicted 2014 would be the year that the sector rotation that pumped up the prices of large and mid cap tech stocks would trickle down to smallcaps. While returns overall are mixed, techs certainly outperformed their mining and metals counterparts. The Venture Exchange stocks that performed […]

BlackBerry Classic beats the iPhone, says Kevin O’Leary

"This thing is crazy fast. It's faster than an iPhone on email. Way faster," says O'Leary.

The new BlackBerry Classic is so superior to the company’s recent devices that it begs the question “What the hell were they thinking for the past three years? says Kevin O’Leary. O’Leary, who was on BNN this morning to review the device that launched today, says that after years as a BlackBerry loyalist, he gave […]

2014 Cantech Letter TSX Venture Tech Stock of the Year: The Finalists

cantech-awards-purple

At the 2014 Cantech Investment Conference, Paradigm’s Barry Richards predicted 2014 would be the year that the sector rotation that pumped up the prices of large and mid cap tech stocks would trickle down to smallcaps. While returns overall are mixed, the techs certainly outperformed their mining and metals counterparts. The Venture Exchange stocks that […]

2014 Cantech Letter TSX Life Sciences Stock of the Year: The Finalists

concordia

It was a wild year for Life Sciences stocks on the TSX, with exciting new entrants and several stocks that raced. Headlines in 2014 were dominated by Valeant’s ultimately unsuccessful bid to acquire Botox-maker Allergan, but were spiked with the stories of Cipher Pharmaceuticals, which soared on the promise of a strong lead drug, the […]

PyroGenesis is undervalued, says Mackie

PyroGenesis CEO Peter Pascali.

PyroGenesis (TSXV:PYR) has a range of opportunities across multiple industries, says Mackie Research Capital analyst Raveel Afzaal. In a research update to clients this morning, Afzaal initiated coverage of PyroGenesis Canada with a “Speculative Buy” recommendation and a 12-month target price of $0.70 per share, implying a return of 126% at the time of publication. […]

The 10 Best Performing TSX Cleantech Stocks of 2014

The Catalyst Paper Mill in Poweel River, B.C. has a history that dates back more than a century. (Photo: Courtesy David Stanley, Flickr. )

It was a pretty bland year for cleantechs in Canada. The S&P/TSX Renewable Energy and Clean Technology Index ended pretty much where it began, and as of Friday, December 12th, the index contained just a single stock that had posted a triple digit gain, and that was just barely. A quarter of the way through […]

Lumenpulse may soon get acquisitive, says Euro Pacific

Lumenpulse worked with Swedish lighting designers Ljusarkitektur to tranform the Åre ski resort into "a magical experience after dark".

A solid Q2 may embolden Lumenpulse (TSX:LMP) to make an acquisition in the second half of its fiscal year, says Euro Pacific Canada analyst Andrej Krneta. Yesterday, Lumenpulse reported its Q2, 2015 results. The company earned $400,000 on revenue of $25.6-million, up 68% over last year’s Q2 topline. “The solid consolidated revenue growth achieved in […]